PCRX FY 2013 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$982M

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$86M+118.9% YoY

Gross Profit

$31M36.0% margin

Operating Income

-$53M-62.3% margin

Net Income

-$64M-74.7% margin

EPS (Diluted)

$-1.93

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$56M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$170M

Total Liabilities

$129M

Stockholders' Equity

$41M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$39M	+118.9%
Gross Profit	$31M	$7M	+343.2%
Operating Income	-$53M	-$49M	-8.1%
Net Income	-$64M	-$52M	-22.2%